文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

早期俯卧位通气对机械通气COVID-19患者30天死亡率的影响:一项全国性队列研究

Prevalence and impact of early prone position on 30-day mortality in mechanically ventilated patients with COVID-19: a nationwide cohort study.
PubMed 文献 · Crit Care · 2022-09-04
一句话结论瑞典全国队列显示,ICU入科时PaO2/FiO2≤20 kPa的机械通气COVID-19患者中,插管24小时内启动俯卧位与30天生存无显著关联。

该研究利用瑞典重症监护登记库(SIR),纳入2020年3月至2021年4月所有≥18岁COVID-19 ICU患者,共6350例,其中46.4%接受俯卧位通气,总体30天死亡率为24.3%。研究人群为入ICU时PaO2/FiO2≤20 kPa且24小时内接受有创机械通气的1714例患者,早期俯卧位使用率从2020年3月的8.5%升至2021年4月的48.1%。该人群粗30天死亡率为27.2%,未接受早期俯卧位者为30.2%,多因素分析未发现早期俯卧位与生存之间存在显著关联。作者结论认为,需进一步研究以阐明COVID-19危重患者俯卧位通气的效果与时机。

要点

  • 研究纳入1714例入ICU时PaO2/FiO2≤20 kPa且24小时内接受有创机械通气的COVID-19患者,早期俯卧位(插管24小时内)与30天生存无显著关联。
  • 该人群粗30天死亡率:接受早期俯卧位者27.2%,未接受者30.2%。
  • 全部6350例COVID-19 ICU患者中46.4%接受俯卧位通气,总体30天死亡率24.3%。
  • 研究人群早期俯卧位使用率从2020年3月的8.5%上升至2021年4月的48.1%。
  • 作者结论认为,需进一步研究以阐明COVID-19危重患者俯卧位通气的效果与时机。

适用人群与场景

  • 瑞典重症监护登记库(SIR)中2020年3月至2021年4月所有≥18岁COVID-19 ICU患者,共6350例。
  • 研究人群:入ICU时PaO2/FiO2≤20 kPa且入ICU后24小时内接受有创机械通气的1714例患者。

诊断标准与关键阈值

  • 研究人群纳入标准:入ICU时PaO2/FiO2≤20 kPa,且入ICU后24小时内接受有创机械通气。
  • 早期俯卧位定义:插管后24小时内使用俯卧位通气。

研究设计与关键结果

  • 研究设计:基于瑞典重症监护登记库(SIR)的全国性队列研究。
  • 总队列6350例COVID-19 ICU患者,46.4%接受俯卧位通气,总体30天死亡率24.3%。
  • 研究人群1714例,早期俯卧位使用率从2020年3月的8.5%上升至2021年4月的48.1%。
  • 研究人群粗30天死亡率:接受早期俯卧位者27.2%,未接受者30.2%。

证据类型、等级与局限

  • 证据类型:全国性队列研究。
  • 局限:原文未报告局限性;作者在结论中提出需进一步研究以阐明俯卧位通气的效果与时机。

对床旁实践的改变

  • 该研究提示,在入ICU时PaO2/FiO2≤20 kPa且24小时内接受有创机械通气的COVID-19患者中,插管24小时内启动俯卧位与30天生存无显著关联。
  • 作者认为,需进一步研究以充分阐明COVID-19危重患者俯卧位通气的效果与时机。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: COVID-19 ARDS shares features with non-COVID ARDS but also demonstrates distinct physiological differences. Despite a lack of strong evidence, prone positioning has been advocated as a key therapy for COVID-19 ARDS. The effects of prone position in critically ill patients with COVID-19 are not fully understood, nor is the optimal time of initiation defined. In this nationwide cohort study, we aimed to investigate the association between early initiation of prone position and mortality in mechanically ventilated COVID-19 patients with low oxygenation on ICU admission.

METHODS: Using the Swedish Intensive Care Registry (SIR), all Swedish ICU patients ≥ 18 years of age with COVID-19 admitted between March 2020, and April 2021 were identified. A study-population of patients with PaO2/FiO2 ratio ≤ 20 kPa on ICU admission and receiving invasive mechanical ventilation within 24 h from ICU admission was generated. In this study-population, the association between early use of prone position (within 24 h from intubation) and 30-day mortality was estimated using univariate and multivariable logistic regression models.

RESULTS: The total study cohort included 6350 ICU patients with COVID-19, of whom 46.4% were treated with prone position ventilation. Overall, 30-day mortality was 24.3%. In the study-population of 1714 patients with lower admission oxygenation (PaO2/FiO2 ratio ≤ 20 kPa), the utilization of early prone increased from 8.5% in March 2020 to 48.1% in April 2021. The crude 30-day mortality was 27.2% compared to 30.2% in patients not receiving early prone positioning. We found no significant association between early use of prone positioning and survival.

CONCLUSIONS: During the first three waves of the COVID-19 pandemic, almost half of the patients in Sweden were treated with prone position ventilation. We found no association between early use of prone positioning and survival in patients on mechanical ventilation with severe hypoxemia on ICU admission. To fully elucidate the effect and timing of prone position ventilation in critically ill patients with COVID-19 further studies are desirable.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Engerström L, Thermaenius J, Mårtensson J, et al. Prevalence and impact of early prone position on 30-day mortality in mechanically ventilated patients with COVID-19: a nationwide cohort study. Crit Care. 2022. PMID: 36058932. doi:10.1186/s13054-022-04122-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。